echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > WHO actively explores next-generation new crown vaccine

    WHO actively explores next-generation new crown vaccine

    • Last Update: 2022-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The Director-General of the World Health Organization Tan Desai said on the 22nd that the world is currently making the most of the available resources of the new crown vaccine to fight the epidemic.
    At the same time, the WHO is working hard to explore the next generation of new crown vaccines through the multi-participation of the new crown vaccine "solidarity test"
    .
    Tan Desai said at the press conference that day that the "Unity Trial" was jointly promoted by the WHO and the health departments of Colombia, Mali and the Philippines.
    The purpose is to accelerate the evaluation of more types of new crown vaccines and expand the types of vaccines available.
    Choose to improve vaccine accessibility
    .
    According to reports, this test will be used to discover second-generation vaccines that can exert better efficacy against mutant new coronaviruses.
    The protective effects of these vaccines are expected to last longer
    .
    The test will also evaluate vaccines that do not require injections
    .
    Tan Desai said that the vaccines that entered the trial project were screened by an independent expert advisory group
    .
    At present, two vaccines have been selected, and three other vaccines will be added in the short term.
    In the future, it is not ruled out that more other vaccines will be selected
    .
    Research teams in Colombia, Mali, and the Philippines began recruiting volunteers to participate in the above-mentioned trial in late September.
    So far, more than 11,500 people have participated in the trial
    .
    Tan Desai said that WHO invites all countries and research institutions to participate in this pilot project
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.